Hepatitis C in the Context of Drug Use; State-of-the-Art Diagnostic and Pathogenic Efforts

Hepatitis C in the Context of Drug Use; State-of-the-Art Diagnostic and Pathogenic Efforts

Time: Mon July 22 2024, 12:00 PM ET

 

Opening Remarks:

Nora Volkow, MD, Director, NIDA

Featured Speakers:

1. Expansion of Point-of-Use Acute HIV infection platform for Hepatitis C Virus

  • Jacqueline C Linnes, PhD, Marta E Gross Professor, Purdue University, West Lafayette, IN

2. Long-term Effects of Intravenous Drug Use, HIV, and HCV, and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women

  • Andrea A.Z.Kovacs, MD, Professor of Pediatrics, Pathology and Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA

Discussion:

Moderator: Andrea Cox; MD, PhD, Professor of Medicine, Johns Hopkins School of Public Health, Baltimore, MD